Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 40.06x is 164% above its 5-year average of 15.19x, around the middle of its 5-year range (-119.54x–233.71x).
37.43% below its 12-month average of 64.02x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 2.28x.
INTEREST COVERAGE RATIO
40.06x
INTEREST COVERAGE RATIO AVG TTM
64.02x
INTEREST COVERAGE RATIO AVG 3Y
17.18x
INTEREST COVERAGE RATIO AVG 5Y
15.19x
INTEREST COVERAGE RATIO AVG 10Y
2.09x
INTEREST COVERAGE RATIO AVG 15Y
-1.84x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-37.43%
CURRENT VS 3Y AVG
+133.18%
CURRENT VS 5Y AVG
+163.79%
CURRENT VS 10Y AVG
+1812.70%
CURRENT VS 15Y AVG
+2281.86%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
+1047.04%
vs the sector median at left
CareCloud, Inc.
Market Cap
$87.75M
Interest Coverage Ratio
40.06x
TTM Avg
64.02x
3Y Avg
17.18x
5Y Avg
15.19x
Market Cap
$87.48M
Interest Coverage Ratio
N/A
TTM Avg
26.56x
3Y Avg
26.56x
5Y Avg
26.56x
Market Cap
$88.21M
Interest Coverage Ratio
3.76x
TTM Avg
3.76x
3Y Avg
3.76x
5Y Avg
2.29x
Market Cap
$86.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$85.90M
Interest Coverage Ratio
-3676.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$85.18M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.52M
Interest Coverage Ratio
9.46x
TTM Avg
9.46x
3Y Avg
9.46x
5Y Avg
9.46x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CareCloud, Inc. (CCLD) | $87.75M | 40.06x | 64.02x | 17.18x | 15.19x |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.48M | N/A | 26.56x | 26.56x | 26.56x |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 3.76x | 3.76x | 3.76x | 2.29x |
| Conexeu Sciences Inc. (CNXU)vs › | $86.43M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.90M | -3676.85x | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.18M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $90.41M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $84.87M | -9.55x | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.52M | 9.46x | 9.46x | 9.46x | 9.46x |
| MediciNova, Inc. (MNOV)vs › | $84.17M | N/A | N/A | N/A | N/A |
Interest Coverage
40.1x
Debt/Equity
3.10
Current Ratio
1.02
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 2.28x |
| 2026-03-31 | 18.22x |
| 2025-12-31 | 233.71x |
| 2025-09-30 | 21.84x |
| 2025-06-30 | 44.06x |
| 2025-03-31 | 34.81x |
| 2024-12-31 | 50.82x |
| 2024-09-30 | 18.24x |
| 2024-06-30 | 7.89x |
| 2024-03-31 | 0.35x |
| 2023-12-31 | -119.54x |
| 2023-09-30 | -5.60x |
| 2023-06-30 | -3.94x |
| 2023-03-31 | -1.49x |
| 2022-12-31 | 9.33x |
| 2022-09-30 | 17.58x |
| 2022-06-30 | 25.74x |
| 2022-03-31 | 12.16x |
| 2021-12-31 | 21.50x |
| 2021-09-30 | 15.66x |
| 2021-06-30 | -0.92x |
| 2021-03-31 | -21.28x |
| 2020-12-31 | 4.38x |
| 2020-09-30 | -10.72x |
| 2020-06-30 | -31.58x |
| 2020-03-31 | -24.04x |
| 2019-12-31 | 8.83x |
| 2019-09-30 | 7.53x |
| 2019-06-30 | -12.21x |
| 2019-03-31 | -2.49x |
| 2018-12-31 | -8.85x |
| 2018-09-30 | -17.01x |
| 2018-06-30 | 0.98x |
| 2018-03-31 | 0.53x |
| 2017-12-31 | -5.57x |
| 2017-09-30 | -0.41x |
| 2017-06-30 | -4.85x |
| 2017-03-31 | -8.62x |
| 2016-12-31 | -19.20x |
| 2016-09-30 | -7.19x |
| 2016-06-30 | -6.35x |
| 2016-03-31 | -12.77x |
| 2015-12-31 | -4.03x |
| 2015-09-30 | -16.90x |
| 2015-06-30 | -34.37x |
| 2015-03-31 | -27.67x |
| 2014-12-31 | -15.46x |
| 2014-09-30 | -60.60x |
| 2014-06-30 | -7.55x |
| 2014-03-31 | -6.11x |
| 2013-12-31 | 4.61x |
| 2013-09-30 | -4.99x |
| 2013-06-30 | -5.09x |
| 2013-03-31 | 0.05x |
| 2012-09-30 | 2.94x |
